Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-14

Clinical Trial Update: Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission [Phase 2]

View source ↗

Summary

A Phase 2 trial examined whether Vitamin A supplementation can reduce HIV presence in vaginal secretions and prevent transmission; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin A (retinol)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Vitamin A Deficiency | Phase 2 | Status: COMPLETED